Abstract

The aim of the study was to evaluate the effect of selenium supplementation on the expression of genes associated with glucose metabolism in humans, in order to explain the unclear relationship between selenium and the risk of diabetes. For gene expression analysis we used archival samples of cDNA from 76 non-diabetic subjects supplemented with selenium in the previous study. The supplementation period was six weeks and the daily dose of selenium was 200 µg (as selenium yeast). Blood for mRNA isolation was collected at four time points: before supplementation, after two and four weeks of supplementation, and after four weeks of washout. The analysis included 15 genes encoding selected proteins involved in insulin signaling and glucose metabolism. In addition, HbA1c and fasting plasma glucose were measured at three and four time points, respectively. Selenium supplementation was associated with a significantly decreased level of HbA1c but not fasting plasma glucose (FPG) and significant down-regulation of seven genes: INSR, ADIPOR1, LDHA, PDHA, PDHB, MYC, and HIF1AN. These results suggest that selenium may affect glycemic control at different levels of regulation, linked to insulin signaling, glycolysis, and pyruvate metabolism. Further research is needed to investigate mechanisms of such transcriptional regulation and its potential implication in direct metabolic effects.

Highlights

  • Selenium (Se) is a trace element with multiple biological functions

  • The aim of this study was to assess the effect of Se supplementation on the expression of genes related to glucose metabolism, including genes encoding hormones responsible for glycemic control, receptors for these hormones, enzymes involved in glycolysis, as well as key transcription factors involved in the regulation of glycolysis

  • On the other hand we did not observe any changes at the level of fasting plasma glucose (FPG)

Read more

Summary

Introduction

Selenium (Se) is a trace element with multiple biological functions. The majority of studies related to this nutrient and human health were devoted to its potential anticancer activity and chemoprevention based on Se supplementation [1,2,3]. In humans associated with elevated Se status has been suggested for the first time on the basis of reanalysis of a placebo-controlled randomized trial (NPC, Nutritional Prevention of Cancer) conducted. There was a significant increase in the risk of diabetes among Se-supplemented subjects who had the highest Se status (plasma concentration >121.6 ng/mL) before supplementation (Risk Ratio (RR) = 2.40; p = 0.01) [7]. In another American study (SELECT, Selenium and Vitamin E Cancer Prevention Trial) conducted in

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call